Genepi Lab
Dr. Mohsen Ghanbari
Dr. Ghanbari
is a medical doctor and molecular epidemiologist. He currently works as an Associate Professor and Principal investigator at Erasmus University Medical Center
Rotterdam in the Netherlands, where he leads the Molecular & Systems Epidemiology research group. He has a multidisciplinary background due to training and working in the clinic, epidemiology and molecular biology. His research focuses on the identification of genetic determinants and novel biomarkers for complex diseases (e.g. Alzheimer’s disease, type 2 diabetes, fatty liver disease). In addition to research, he is a dedicated teacher in multiple courses offered by the Netherlands Institute for Health Sciences (NIHES) and coordinates ‘omics’ data in the population based Rotterdam Study cohort and the Erasmus Rucphen Family study.
miRNA Lab
miRNAs are small, non-coding RNAs that regulate gene expression by binding to the 3′ untranslated region (3′ UTR) of target mRNAs. miRNA lab features typically include the ability to sequence and analyze miRNA expression from a variety of sources, including cell lines, tissues, and organisms. Additionally, miRNA expression can be measured and analyzed in response to various physiological stimuli. Lab features may also include the ability to predict miRNA target sites, as well as to measure and analyze miRNA-mRNA interactions. Finally, miRNA lab features may also include the ability to characterize miRNA-mediated gene regulation and its associated effects on gene expression and cellular processes.
Alborn vito
mos nostra pertrone
Dr. Ghanbari is a medical doctor and molecular epidemiologist. He currently works as Associate Professor and Principal investigator at Erasmus University Medical Center Rotterdam in the Netherlands, where he leads the Molecular & Systems Epidemiology research group. He has a multidisciplinary background due to training and working in the clinic, epidemiology and molecular biology. His research focuses on the identification of genetic determinants and novel biomarkers for complex diseases (e.g. Alzheimer’s disease, type 2 diabetes, fatty liver disease). In addition to research, he is a dedicated teacher in multiple courses offered by the Netherlands Institute for Health Sciences (NIHES) and coordinates ‘omics’ data in the population-based Rotterdam Study cohort and the Erasmus Rucphen Family study.
Our social funpages
Follow us on social media